abrdn Life Sciences Investors
HQL
79 hedge funds and large institutions have $113M invested in abrdn Life Sciences Investors in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 10 closing their positions.
41% more capital invested
Capital invested by funds: $80.4M → $113M (+$32.6M)
39% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 23
7.41% more ownership
Funds ownership: 24.59% → 32% (+7.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
1% less funds holding
Funds holding: 80 → 79 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$14.1M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$3.01M |
| 3 |
CA
Cornerstone Advisors
Asheville,
North Carolina
|
+$2.58M |
| 4 |
Morgan Stanley
New York
|
+$2.45M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TJHA
Thomas J. Herzfeld Advisors
Miami Beach,
Florida
|
-$1.43M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.41M |
| 3 |
LSC
Logan Stone Capital
Chicago,
Illinois
|
-$1.2M |
| 4 |
Walleye Capital
New York
|
-$623K |
| 5 |
Cohen & Steers
New York
|
-$468K |
HQL Hedge Fund Activity: Q4 2023 in Review
79 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2023, worth a combined $113M — up 41% from $80.4M a quarter earlier.
Fund positioning in HQL was balanced in Q4 2023: 10 funds opened new positions, 10 closed out, 32 added to existing stakes and 23 trimmed.
The largest buyer was Saba Capital Management, adding an estimated $14.1M. The largest seller was Thomas J. Herzfeld Advisors, cutting an estimated $1.43M.
- 79 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2023, down from 80 in Q3 2023.
- Funds reported $113M of abrdn Life Sciences Investors stock for Q4 2023, up 41% quarter-over-quarter.
- 10 funds opened new abrdn Life Sciences Investors positions in Q4 2023 and 10 closed out, a net change of 0 holders.
- The largest abrdn Life Sciences Investors buyer in Q4 2023 was Saba Capital Management, an estimated $14.1M added.
- The largest abrdn Life Sciences Investors seller in Q4 2023 was Thomas J. Herzfeld Advisors, an estimated $1.43M sold.
Based on aggregated 13F filings for Q4 2023.